David A. Eavarone

1.3k total citations · 1 hit paper
10 papers, 988 citations indexed

About

David A. Eavarone is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David A. Eavarone has authored 10 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David A. Eavarone's work include Glycosylation and Glycoproteins Research (6 papers), Cancer Research and Treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). David A. Eavarone is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Cancer Research and Treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). David A. Eavarone collaborates with scholars based in United States and New Zealand. David A. Eavarone's co-authors include Tanyel Kiziltepe, Ram Sasisekharan, Shiladitya Sengupta, Ganlin Zhao, Nicki Watson, Ishan Capila, Ravi V. Bellamkonda, Xiaojun Yu, Jillian M. Prendergast and Bo R. Rueda and has published in prestigious journals such as Nature, Circulation and PLoS ONE.

In The Last Decade

David A. Eavarone

10 papers receiving 960 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

2005 766 citations Shiladitya Sengupta, David A. Eavarone et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Eavarone United States	7	518	470	420	149	93	10	988
Abby M. Gonik United States	5	766 1.5×	489 1.0×	511 1.2×	173 1.2×	90 1.0×	6	1.2k
Jennifer I. Hare United Kingdom	9	737 1.4×	417 0.9×	585 1.4×	156 1.0×	144 1.5×	12	1.2k
In-San Kim South Korea	14	712 1.4×	587 1.2×	639 1.5×	233 1.6×	78 0.8×	16	1.4k
Wayne Ngo Canada	12	503 1.0×	492 1.0×	520 1.2×	197 1.3×	98 1.1×	20	1.2k
Aeju Lee South Korea	23	401 0.8×	681 1.4×	569 1.4×	195 1.3×	160 1.7×	38	1.4k
Luisa M. Russell United States	11	474 0.9×	440 0.9×	468 1.1×	116 0.8×	85 0.9×	14	984
Mami Murakami Canada	7	904 1.7×	490 1.0×	713 1.7×	172 1.2×	191 2.1×	8	1.4k
Catherine Passirani France	18	565 1.1×	432 0.9×	385 0.9×	158 1.1×	133 1.4×	20	1.1k
Remon Bazak Egypt	7	507 1.0×	364 0.8×	467 1.1×	145 1.0×	83 0.9×	13	915
Gahininath Y. Bharate Japan	5	605 1.2×	389 0.8×	375 0.9×	130 0.9×	119 1.3×	7	993

Countries citing papers authored by David A. Eavarone

Since Specialization

Citations

This map shows the geographic impact of David A. Eavarone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Eavarone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Eavarone more than expected).

Fields of papers citing papers by David A. Eavarone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Eavarone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Eavarone. The network helps show where David A. Eavarone may publish in the future.

Co-authorship network of co-authors of David A. Eavarone

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Eavarone. A scholar is included among the top collaborators of David A. Eavarone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Eavarone. David A. Eavarone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Eavarone, David A., Linah Al-Alem, Alexey A. Lugovskoy, et al.. (2018). Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma. PLoS ONE. 13(7). e0201314–e0201314. 30 indexed citations

2.

Eavarone, David A., Patricia E. Rao, Jillian M. Prendergast, et al.. (2018). Abstract 5625: Myeloid derived suppressor cells (MDSCs) express Sialyl Tn (STn) and are a therapeutic target for anti-STn antibody drug conjugates. Cancer Research. 78(13_Supplement). 5625–5625. 1 indexed citations

3.

Starbuck, Kristen, Linah Al-Alem, David A. Eavarone, et al.. (2018). Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau. Oncotarget. 9(33). 23289–23305. 19 indexed citations

4.

Eavarone, David A., et al.. (2017). Abstract 3640: Novel humanized anti-Sialyl-Tn, anti-CD3 bispecific antibodies demonstrate tumor and T-cell specificity for immune activation at the tumor site. Cancer Research. 77(13_Supplement). 3640–3640. 2 indexed citations

5.

Prendergast, Jillian M., Ana Paula da Silva, David A. Eavarone, et al.. (2017). Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity. mAbs. 9(4). 615–627. 52 indexed citations

6.

Starbuck, Kristen, et al.. (2015). Eradicating ovarian cancer stem cells by targeting the tumor-associated carbohydrate antigen sialyl Tn. Gynecologic Oncology. 139(3). 590–590. 1 indexed citations

7.

Harfouche, Rania, Dirk M. Hentschel, Sudipta Basu, et al.. (2009). Glycome and Transcriptome Regulation of Vasculogenesis. Circulation. 120(19). 1883–1892. 20 indexed citations

8.

Sengupta, Shiladitya, David A. Eavarone, Ishan Capila, et al.. (2005). Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 436(7050). 568–572. 766 indexed citations breakdown →

9.

Eavarone, David A., Xiaojun Yu, & Ravi V. Bellamkonda. (2000). Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. Journal of Biomedical Materials Research. 51(1). 10–14. 91 indexed citations

10.

Eavarone, David A., Xiaojun Yu, & Ravi V. Bellamkonda. (2000). Targeted drug delivery to C6 glioma by transferrin‐coupled liposomes. Journal of Biomedical Materials Research. 51(1). 10–14. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact